Cybele Kristo


    Publications 2009

    Lekva T, Bollerslev J, Kristo C, Olstad OK, Ueland T, Jemtland R (2009)
    The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis
    J Clin Endocrinol Metab, 95 (1), 246-55
    DOI 10.1210/jc.2009-0595, PubMed 19875485

    Publications 2008

    Kristo C, Ueland T, Godang K, Aukrust P, Bollerslev J (2008)
    Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome
    J Endocrinol Invest, 31 (5), 400-5
    DOI 10.1007/BF03346383, PubMed 18560257

    Publications 2007

    Kristo C (2007)
    Endogenous Cushing's syndrome: bone metabolism and body composition
    In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 553, 1 b. (flere pag.)
    BIBSYS 080051952, ISBN 978-82-8072-720-6

    Publications 2006

    Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006)
    Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study
    Eur J Endocrinol, 154 (1), 109-18
    DOI 10.1530/eje.1.02067, PubMed 16381999

    Publications 2005

    Bollerslev J, Hallén J, Fougner KJ, Jørgensen AP, Kristo C, Fagertun H, Gudmundsen O, Burman P, Schreiner T (2005)
    Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
    Eur J Endocrinol, 153 (3), 379-87
    DOI 10.1530/eje.1.01971, PubMed 16131600

    Publications 2003

    Ueland T, Kristo C, Godang K, Aukrust P, Bollerslev J (2003)
    Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study
    J Clin Endocrinol Metab, 88 (4), 1492-6
    DOI 10.1210/jc.2002-021030, PubMed 12679428

    Publications 2002

    Egerton JR, Ghimire SC, Dhungyel OP, Shrestha HK, Joshi HD, Joshi BR, Abbott KA, Kristo C (2002)
    Eradication of virulent footrot from sheep and goats in an endemic area of Nepal and an evaluation of specific vaccination
    Vet Rec, 151 (10), 290-5
    DOI 10.1136/vr.151.10.290, PubMed 12243270

    Kristo C, Godang K, Ueland T, Lien E, Aukrust P, Froland SS, Bollerslev J (2002)
    Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome
    Eur J Endocrinol, 146 (3), 389-95
    DOI 10.1530/eje.0.1460389, PubMed 11888846

    Publications 1994

    Kristo C, Schlichting E, Buanes T (1994)
    [Surgical treatment of gastrointestinal malignant melanoma]
    Tidsskr Nor Laegeforen, 114 (8), 912-4
    PubMed 8191466

    Raadsma HW, Egerton JR, Wood D, Kristo C, Nicholas FW (1994)
    Disease resistance in Merino sheep. III. Genetic variation in resistance to footrot following challenge and subsequent vaccination with an homologous rDNA pilus vaccine under both induced and natural conditions
    J Anim Breed Genet, 111 (1-6), 367-90
    DOI 10.1111/j.1439-0388.1994.tb00475.x, PubMed 21395787

    Publications 1987

    Egerton JR, Cox PT, Anderson BJ, Kristo C, Norman M, Mattick JS (1987)
    Protection of sheep against footrot with a recombinant DNA-based fimbrial vaccine
    Vet Microbiol, 14 (4), 393-409
    DOI 10.1016/0378-1135(87)90030-7, PubMed 2891214

    Page visits: 4502